Upsher-Smith Labs on Wednesday announced that it has agreed to acquire Proximagen Group, a European biotechnology company focused on the development and commercialization of novel therapeutics for diseases of the central nervous system and inflammation.
Drug maker Genzyme plans to present data from trial programs of two multiple sclerosis drugs at the American Academy of Neurology's annual meeting in New Orleans, which starts this Saturday and lasts until next Saturday.
Nielsen Holdings on Monday announced that Rick Kash has been appointed vice chair and will join CEO David Calhoun and vice chair Susan Whiting in the office of the CEO. Nielsen also named Mitchell Habib COO.
Cambridge Consultants on Thursday released a report outlining how the health-and-wellness market may take shape as more consumer-friendly medical devices featuring the latest in technology reach the market.
Grocer A&P recently completed the previously announced auction of 25 Southern Superfresh locations as it continues to implement its financial and operational restructuring, the company announced on Wednesday.
A drug under investigation as a treatment for a rare genetic disorder that causes abnormally high triglyceride levels in the blood has received orphan-drug designation from the Food and Drug Administration.